Rank | Gene Set | Z-score |
---|---|---|
1 | protein neddylation (GO:0045116) | 8.00398204 |
2 | neutrophil activation involved in immune response (GO:0002283) | 7.53163074 |
3 | thrombin receptor signaling pathway (GO:0070493) | 7.43848099 |
4 | atrioventricular valve morphogenesis (GO:0003181) | 6.38169851 |
5 | endocardial cushion development (GO:0003197) | 6.19879152 |
6 | regulation of platelet aggregation (GO:0090330) | 6.04009923 |
7 | urate metabolic process (GO:0046415) | 5.96062428 |
8 | drug transmembrane transport (GO:0006855) | 5.92285203 |
9 | lysine catabolic process (GO:0006554) | 5.74244329 |
10 | lysine metabolic process (GO:0006553) | 5.74244329 |
11 | regulation of platelet activation (GO:0010543) | 5.55743010 |
12 | regulation of cardioblast differentiation (GO:0051890) | 5.44359660 |
13 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.44135316 |
14 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.43892747 |
15 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.43080132 |
16 | organic cation transport (GO:0015695) | 5.40859832 |
17 | platelet aggregation (GO:0070527) | 5.24959855 |
18 | blood coagulation, intrinsic pathway (GO:0007597) | 5.22218484 |
19 | adenosine receptor signaling pathway (GO:0001973) | 5.20354628 |
20 | positive regulation of endothelial cell differentiation (GO:0045603) | 5.12135582 |
21 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.02098110 |
22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.94249527 |
23 | drug transport (GO:0015893) | 4.84685380 |
24 | phosphate ion transport (GO:0006817) | 4.82299651 |
25 | quaternary ammonium group transport (GO:0015697) | 4.81183110 |
26 | negative regulation of norepinephrine secretion (GO:0010700) | 4.72348015 |
27 | atrial septum morphogenesis (GO:0060413) | 4.67736660 |
28 | basement membrane organization (GO:0071711) | 4.66835368 |
29 | positive regulation of mast cell activation (GO:0033005) | 4.66766637 |
30 | negative regulation of platelet activation (GO:0010544) | 4.62781694 |
31 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.61895803 |
32 | neutrophil activation (GO:0042119) | 4.54148550 |
33 | lipoxygenase pathway (GO:0019372) | 4.45828891 |
34 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.43661452 |
35 | negative regulation of heart growth (GO:0061117) | 4.43589549 |
36 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 4.43589549 |
37 | negative regulation of heart rate (GO:0010459) | 4.41821838 |
38 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.33903112 |
39 | negative regulation of protein localization to cell surface (GO:2000009) | 4.28306514 |
40 | cell migration involved in heart development (GO:0060973) | 4.23909553 |
41 | angiogenesis involved in wound healing (GO:0060055) | 4.22557727 |
42 | regulation of cardioblast proliferation (GO:0003264) | 4.21173117 |
43 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 4.21173117 |
44 | phosphate ion transmembrane transport (GO:0035435) | 4.20527953 |
45 | pericardium development (GO:0060039) | 4.16248853 |
46 | carnitine transport (GO:0015879) | 4.16164628 |
47 | amino-acid betaine transport (GO:0015838) | 4.16164628 |
48 | response to mercury ion (GO:0046689) | 4.14086203 |
49 | metanephric nephron tubule development (GO:0072234) | 4.10819737 |
50 | metanephric tubule development (GO:0072170) | 4.10819737 |
51 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.10688898 |
52 | platelet degranulation (GO:0002576) | 4.06080270 |
53 | positive regulation of macrophage differentiation (GO:0045651) | 4.04986343 |
54 | muscle filament sliding (GO:0030049) | 4.04040400 |
55 | actin-myosin filament sliding (GO:0033275) | 4.04040400 |
56 | cysteine metabolic process (GO:0006534) | 4.03146857 |
57 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.00523682 |
58 | granulocyte activation (GO:0036230) | 3.98764445 |
59 | regulation of lipoprotein metabolic process (GO:0050746) | 3.96855378 |
60 | polyamine biosynthetic process (GO:0006596) | 3.95500479 |
61 | negative regulation of appetite (GO:0032099) | 3.86277578 |
62 | negative regulation of response to food (GO:0032096) | 3.86277578 |
63 | metanephric nephron epithelium development (GO:0072243) | 3.85676530 |
64 | low-density lipoprotein particle remodeling (GO:0034374) | 3.81333892 |
65 | megakaryocyte development (GO:0035855) | 3.80652496 |
66 | tricarboxylic acid metabolic process (GO:0072350) | 3.79074938 |
67 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.76967046 |
68 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.76374537 |
69 | renal absorption (GO:0070293) | 3.75182741 |
70 | plasma membrane repair (GO:0001778) | 3.73982126 |
71 | regulation of integrin activation (GO:0033623) | 3.70788658 |
72 | homotypic cell-cell adhesion (GO:0034109) | 3.68719382 |
73 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.68145574 |
74 | fibroblast migration (GO:0010761) | 3.66496334 |
75 | actin-mediated cell contraction (GO:0070252) | 3.66088410 |
76 | aspartate family amino acid catabolic process (GO:0009068) | 3.64749857 |
77 | platelet formation (GO:0030220) | 3.64260813 |
78 | platelet activation (GO:0030168) | 3.63846739 |
79 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.61870255 |
80 | regulation of skeletal muscle contraction (GO:0014819) | 3.61737106 |
81 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.60661217 |
82 | 2-oxoglutarate metabolic process (GO:0006103) | 3.58110494 |
83 | cardiac chamber formation (GO:0003207) | 3.57479780 |
84 | positive regulation of receptor recycling (GO:0001921) | 3.56565699 |
85 | excretion (GO:0007588) | 3.56226192 |
86 | cGMP-mediated signaling (GO:0019934) | 3.52580398 |
87 | metanephric epithelium development (GO:0072207) | 3.52290942 |
88 | glyoxylate metabolic process (GO:0046487) | 3.51498381 |
89 | valine metabolic process (GO:0006573) | 3.50545122 |
90 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.47721899 |
91 | purinergic receptor signaling pathway (GO:0035587) | 3.46312543 |
92 | cellular response to vitamin D (GO:0071305) | 3.45892648 |
93 | vitamin D metabolic process (GO:0042359) | 3.45879882 |
94 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.44516766 |
95 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.43970275 |
96 | regulation of endothelial cell differentiation (GO:0045601) | 3.42693144 |
97 | cellular response to vitamin (GO:0071295) | 3.41797904 |
98 | nephron tubule development (GO:0072080) | 3.37172263 |
99 | cell adhesion mediated by integrin (GO:0033627) | 3.37114862 |
100 | positive regulation of blood coagulation (GO:0030194) | 3.35112820 |
101 | positive regulation of hemostasis (GO:1900048) | 3.35112820 |
102 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.34732212 |
103 | negative regulation of heart contraction (GO:0045822) | 3.33066527 |
104 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.32419622 |
105 | extracellular fibril organization (GO:0043206) | 3.30832884 |
106 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.30388896 |
107 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.28822497 |
108 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.28822497 |
109 | regulation of norepinephrine secretion (GO:0014061) | 3.28661657 |
110 | autophagic vacuole fusion (GO:0000046) | 3.26964430 |
111 | heart valve morphogenesis (GO:0003179) | 3.26219185 |
112 | termination of signal transduction (GO:0023021) | 3.25242959 |
113 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.24891040 |
114 | drug catabolic process (GO:0042737) | 3.23483950 |
115 | sarcomere organization (GO:0045214) | 3.21395684 |
116 | exogenous drug catabolic process (GO:0042738) | 3.21012643 |
117 | branched-chain amino acid metabolic process (GO:0009081) | 3.17798389 |
118 | regulation of mast cell activation (GO:0033003) | 3.13415671 |
119 | negative regulation of T cell apoptotic process (GO:0070233) | 3.11652465 |
120 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.11418844 |
121 | trivalent inorganic anion homeostasis (GO:0072506) | 3.10286522 |
122 | phosphate ion homeostasis (GO:0055062) | 3.10286522 |
123 | beta-amyloid metabolic process (GO:0050435) | 3.09719674 |
124 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.07751082 |
125 | leukocyte degranulation (GO:0043299) | 3.07263988 |
126 | regulation of memory T cell differentiation (GO:0043380) | 3.05786099 |
127 | phagocytosis, engulfment (GO:0006911) | 3.04923659 |
128 | actin filament-based movement (GO:0030048) | 3.03326243 |
129 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.01764548 |
130 | positive regulation of mast cell degranulation (GO:0043306) | 3.01764548 |
131 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.00372015 |
132 | positive regulation of coagulation (GO:0050820) | 2.99646134 |
133 | ventricular septum development (GO:0003281) | 2.98404214 |
134 | regulation of regulatory T cell differentiation (GO:0045589) | 2.98380712 |
135 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.98261261 |
136 | renal tubule development (GO:0061326) | 2.97711134 |
137 | skeletal muscle tissue regeneration (GO:0043403) | 2.97651487 |
138 | adenosine metabolic process (GO:0046085) | 2.96180788 |
139 | short-chain fatty acid metabolic process (GO:0046459) | 2.95158554 |
140 | epithelial cell-cell adhesion (GO:0090136) | 2.95059560 |
141 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.94157204 |
142 | peptide catabolic process (GO:0043171) | 2.93683177 |
143 | carnitine transmembrane transport (GO:1902603) | 2.93615586 |
144 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.91200607 |
145 | regulation of mast cell degranulation (GO:0043304) | 2.91129603 |
146 | nephron epithelium development (GO:0072009) | 2.90674223 |
147 | renal filtration (GO:0097205) | 2.89228264 |
148 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.87535149 |
149 | regulation of receptor recycling (GO:0001919) | 2.87218274 |
150 | regulation of female receptivity (GO:0045924) | 2.87015944 |
151 | negative regulation of catecholamine secretion (GO:0033604) | 2.86669250 |
152 | regulation of blood coagulation (GO:0030193) | 2.85763702 |
153 | regulation of hemostasis (GO:1900046) | 2.85763702 |
154 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.84963139 |
155 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.84850092 |
156 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.84064889 |
157 | vesicle targeting (GO:0006903) | 2.83531229 |
158 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.83014146 |
159 | fibril organization (GO:0097435) | 2.82345732 |
160 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 2.81904785 |
161 | response to parathyroid hormone (GO:0071107) | 2.81621523 |
162 | mitochondrial calcium ion transport (GO:0006851) | 2.81252896 |
163 | toxin transport (GO:1901998) | 2.80341943 |
164 | sequestering of actin monomers (GO:0042989) | 2.79037203 |
165 | cardiac septum development (GO:0003279) | 2.78961182 |
166 | renal tubule morphogenesis (GO:0061333) | 2.77844790 |
167 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.77541645 |
168 | plasma membrane fusion (GO:0045026) | 2.77394728 |
169 | high-density lipoprotein particle remodeling (GO:0034375) | 2.77155353 |
170 | fatty acid beta-oxidation (GO:0006635) | 2.75114815 |
171 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.73986969 |
172 | response to growth hormone (GO:0060416) | 2.72908841 |
173 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.72737581 |
174 | amine biosynthetic process (GO:0009309) | 2.72345280 |
175 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.72313098 |
176 | positive regulation of B cell mediated immunity (GO:0002714) | 2.72313098 |
177 | actin filament depolymerization (GO:0030042) | 2.70862272 |
178 | chondrocyte proliferation (GO:0035988) | 2.70464693 |
179 | glomerular filtration (GO:0003094) | 2.67652663 |
180 | venous blood vessel morphogenesis (GO:0048845) | 2.66111497 |
181 | response to phenylpropanoid (GO:0080184) | 2.64230284 |
182 | carnitine shuttle (GO:0006853) | 2.62808273 |
183 | carnitine metabolic process (GO:0009437) | 2.61371517 |
184 | glutathione biosynthetic process (GO:0006750) | 2.60608033 |
185 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 2.60047561 |
186 | homocysteine metabolic process (GO:0050667) | 2.59762259 |
187 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.58948324 |
188 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.58861812 |
189 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.57560366 |
190 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.57212964 |
191 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.56642945 |
192 | cardiac ventricle formation (GO:0003211) | 2.56614937 |
193 | amino-acid betaine metabolic process (GO:0006577) | 2.55425850 |
194 | fatty acid oxidation (GO:0019395) | 2.54504343 |
195 | cellular modified amino acid catabolic process (GO:0042219) | 2.50369974 |
196 | regulation of heart morphogenesis (GO:2000826) | 2.49688761 |
197 | nephron tubule morphogenesis (GO:0072078) | 2.49102190 |
198 | nephron epithelium morphogenesis (GO:0072088) | 2.49102190 |
199 | glomerular basement membrane development (GO:0032836) | 2.48895594 |
200 | lipid oxidation (GO:0034440) | 2.47945587 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.06247881 |
2 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.51413984 |
3 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.02163072 |
4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.73544085 |
5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.72738434 |
6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.55047004 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.27872254 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.12692993 |
9 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.97655970 |
10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.97229215 |
11 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.92508691 |
12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.74795263 |
13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.71050312 |
14 | GATA1_19941826_ChIP-Seq_K562_Human | 2.66412595 |
15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.65509753 |
16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.62018964 |
17 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.58248106 |
18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.55946660 |
19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.39905988 |
20 | GATA2_19941826_ChIP-Seq_K562_Human | 2.36770997 |
21 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.30598109 |
22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.26406541 |
23 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.23704440 |
24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.20931878 |
25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19118725 |
26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12882924 |
27 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.12155998 |
28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.10359631 |
29 | CJUN_26792858_Chip-Seq_BT549_Human | 2.05223309 |
30 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.98783751 |
31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.98713185 |
32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93094041 |
33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.92989446 |
34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91333064 |
35 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.90882871 |
36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.89693776 |
37 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.89675400 |
38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.86376697 |
39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.85119682 |
40 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.84763052 |
41 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.84055345 |
42 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.83788405 |
43 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.81515023 |
44 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.81471142 |
45 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.81471142 |
46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.78398873 |
47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77860963 |
48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.75770540 |
49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73344167 |
50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70337806 |
51 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.68585042 |
52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.66495180 |
53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.66495180 |
54 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66043965 |
55 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.61593772 |
56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61196366 |
57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.60936730 |
58 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60739169 |
59 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60426006 |
60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.59568498 |
61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.57702172 |
62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57334232 |
63 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.56603263 |
64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.55353972 |
65 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.55324781 |
66 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.54817628 |
67 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.53909366 |
68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53274417 |
69 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.49705811 |
70 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.49559627 |
71 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.48879849 |
72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47956932 |
73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42970972 |
74 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40158094 |
75 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.36718002 |
76 | TP53_16413492_ChIP-PET_HCT116_Human | 1.36260703 |
77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35861859 |
78 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33581695 |
79 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.30569273 |
80 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.30385389 |
81 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.28837489 |
82 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.27445665 |
83 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26075280 |
84 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25936416 |
85 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25105077 |
86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25024334 |
87 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24293746 |
88 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24208339 |
89 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.23857286 |
90 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.23419058 |
91 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.21003372 |
92 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.18135804 |
93 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.17478925 |
94 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.17157032 |
95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16342889 |
96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15873630 |
97 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15741710 |
98 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.14335382 |
99 | RXR_22108803_ChIP-Seq_LS180_Human | 1.12616441 |
100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11819041 |
101 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11518501 |
102 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.10793996 |
103 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10082545 |
104 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10017778 |
105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08317508 |
106 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.07609035 |
107 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07370734 |
108 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06433601 |
109 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.06213232 |
110 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06158481 |
111 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05992610 |
112 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.05347130 |
113 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03979475 |
114 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03201080 |
115 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02795740 |
116 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02282553 |
117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01913702 |
118 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01706670 |
119 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01684643 |
120 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00874477 |
121 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00428962 |
122 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.99410076 |
123 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.98725908 |
124 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98578310 |
125 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98422170 |
126 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98201102 |
127 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98008511 |
128 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.97830579 |
129 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.97499531 |
130 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97150484 |
131 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96886315 |
132 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96739548 |
133 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96739548 |
134 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.95991354 |
135 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95949223 |
136 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.95431459 |
137 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94698101 |
138 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94434855 |
139 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94213948 |
140 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93996715 |
141 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.93144656 |
142 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92402116 |
143 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91910541 |
144 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91891114 |
145 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91796261 |
146 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91312735 |
147 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.91253977 |
148 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91136388 |
149 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91088943 |
150 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90972555 |
151 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90945434 |
152 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89942243 |
153 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.89698415 |
154 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.88866582 |
155 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88671905 |
156 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.88526375 |
157 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.88445897 |
158 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.88381467 |
159 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88327656 |
160 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88311918 |
161 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87724564 |
162 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.87652753 |
163 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.87251434 |
164 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86410793 |
165 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.86399471 |
166 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.86060645 |
167 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.85980384 |
168 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85810431 |
169 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.85484488 |
170 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85423684 |
171 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.84727796 |
172 | MYB_26560356_Chip-Seq_TH2_Human | 0.84181485 |
173 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83771732 |
174 | AR_25329375_ChIP-Seq_VCAP_Human | 0.83713608 |
175 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.83124434 |
176 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82525205 |
177 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.82284381 |
178 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81959897 |
179 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.81773795 |
180 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81654112 |
181 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.81463221 |
182 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.81169516 |
183 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79964269 |
184 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.79172297 |
185 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.79172297 |
186 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.79062118 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005464_abnormal_platelet_physiology | 9.66139928 |
2 | MP0008004_abnormal_stomach_pH | 5.31251846 |
3 | MP0003724_increased_susceptibility_to | 4.06447642 |
4 | MP0005360_urolithiasis | 3.87654668 |
5 | MP0005503_abnormal_tendon_morphology | 3.72303526 |
6 | MP0000465_gastrointestinal_hemorrhage | 3.25082216 |
7 | MP0000751_myopathy | 3.14573275 |
8 | MP0004043_abnormal_pH_regulation | 3.11887170 |
9 | MP0001958_emphysema | 2.97135603 |
10 | MP0004510_myositis | 2.89414782 |
11 | MP0005623_abnormal_meninges_morphology | 2.80619696 |
12 | MP0000749_muscle_degeneration | 2.70519398 |
13 | MP0004272_abnormal_basement_membrane | 2.69965910 |
14 | MP0001835_abnormal_antigen_presentation | 2.57764800 |
15 | MP0005332_abnormal_amino_acid | 2.46176348 |
16 | MP0008438_abnormal_cutaneous_collagen | 2.40787307 |
17 | MP0005083_abnormal_biliary_tract | 2.40230484 |
18 | MP0000343_altered_response_to | 2.35400021 |
19 | MP0003303_peritoneal_inflammation | 2.34570673 |
20 | MP0000747_muscle_weakness | 2.34503525 |
21 | MP0004145_abnormal_muscle_electrophysio | 2.29395904 |
22 | MP0009384_cardiac_valve_regurgitation | 2.27720643 |
23 | MP0002736_abnormal_nociception_after | 2.19603727 |
24 | MP0004019_abnormal_vitamin_homeostasis | 2.10708775 |
25 | MP0003566_abnormal_cell_adhesion | 2.07261480 |
26 | MP0009643_abnormal_urine_homeostasis | 2.06241338 |
27 | MP0001765_abnormal_ion_homeostasis | 2.01025479 |
28 | MP0002139_abnormal_hepatobiliary_system | 1.98739029 |
29 | MP0002108_abnormal_muscle_morphology | 1.97725295 |
30 | MP0002138_abnormal_hepatobiliary_system | 1.97086207 |
31 | MP0003705_abnormal_hypodermis_morpholog | 1.94105379 |
32 | MP0005620_abnormal_muscle_contractility | 1.93823391 |
33 | MP0005671_abnormal_response_to | 1.86803474 |
34 | MP0002837_dystrophic_cardiac_calcinosis | 1.85687567 |
35 | MP0000750_abnormal_muscle_regeneration | 1.82545761 |
36 | MP0004084_abnormal_cardiac_muscle | 1.82028528 |
37 | MP0005330_cardiomyopathy | 1.77893463 |
38 | MP0002269_muscular_atrophy | 1.76633783 |
39 | MP0000733_abnormal_muscle_development | 1.74963429 |
40 | MP0001756_abnormal_urination | 1.74848894 |
41 | MP0002148_abnormal_hypersensitivity_rea | 1.72776247 |
42 | MP0004036_abnormal_muscle_relaxation | 1.71845444 |
43 | MP0004087_abnormal_muscle_fiber | 1.71496001 |
44 | MP0005000_abnormal_immune_tolerance | 1.69791714 |
45 | MP0010155_abnormal_intestine_physiology | 1.69091728 |
46 | MP0003195_calcinosis | 1.68854106 |
47 | MP0005167_abnormal_blood-brain_barrier | 1.68203069 |
48 | MP0005275_abnormal_skin_tensile | 1.66094008 |
49 | MP0008872_abnormal_physiological_respon | 1.64990616 |
50 | MP0003638_abnormal_response/metabolism_ | 1.64894881 |
51 | MP0003252_abnormal_bile_duct | 1.63481256 |
52 | MP0002136_abnormal_kidney_physiology | 1.62340246 |
53 | MP0003279_aneurysm | 1.59772249 |
54 | MP0005369_muscle_phenotype | 1.58624933 |
55 | MP0003879_abnormal_hair_cell | 1.57774047 |
56 | MP0001851_eye_inflammation | 1.57183979 |
57 | MP0005410_abnormal_fertilization | 1.56240972 |
58 | MP0004233_abnormal_muscle_weight | 1.56015998 |
59 | MP0002106_abnormal_muscle_physiology | 1.55259991 |
60 | MP0003436_decreased_susceptibility_to | 1.54841874 |
61 | MP0003646_muscle_fatigue | 1.53363394 |
62 | MP0003300_gastrointestinal_ulcer | 1.49949751 |
63 | MP0002132_abnormal_respiratory_system | 1.48415740 |
64 | MP0004130_abnormal_muscle_cell | 1.46028207 |
65 | MP0005646_abnormal_pituitary_gland | 1.45281324 |
66 | MP0002398_abnormal_bone_marrow | 1.43364767 |
67 | MP0000249_abnormal_blood_vessel | 1.42147405 |
68 | MP0002972_abnormal_cardiac_muscle | 1.40865194 |
69 | MP0009250_abnormal_appendicular_skeleto | 1.39977793 |
70 | MP0002168_other_aberrant_phenotype | 1.38997404 |
71 | MP0001663_abnormal_digestive_system | 1.36469482 |
72 | MP0002896_abnormal_bone_mineralization | 1.35305718 |
73 | MP0002089_abnormal_postnatal_growth/wei | 1.35179359 |
74 | MP0001533_abnormal_skeleton_physiology | 1.34551351 |
75 | MP0001545_abnormal_hematopoietic_system | 1.33289764 |
76 | MP0005397_hematopoietic_system_phenotyp | 1.33289764 |
77 | MP0001968_abnormal_touch/_nociception | 1.32688759 |
78 | MP0002723_abnormal_immune_serum | 1.31869166 |
79 | MP0008775_abnormal_heart_ventricle | 1.31148413 |
80 | MP0003045_fibrosis | 1.30734874 |
81 | MP0000759_abnormal_skeletal_muscle | 1.29584262 |
82 | MP0001800_abnormal_humoral_immune | 1.28291984 |
83 | MP0003941_abnormal_skin_development | 1.26428570 |
84 | MP0009764_decreased_sensitivity_to | 1.25723145 |
85 | MP0004484_altered_response_of | 1.25722144 |
86 | MP0010368_abnormal_lymphatic_system | 1.24704874 |
87 | MP0005058_abnormal_lysosome_morphology | 1.23771524 |
88 | MP0004947_skin_inflammation | 1.23254952 |
89 | MP0002452_abnormal_antigen_presenting | 1.22984507 |
90 | MP0009763_increased_sensitivity_to | 1.22712025 |
91 | MP0002009_preneoplasia | 1.21808634 |
92 | MP0003091_abnormal_cell_migration | 1.20560275 |
93 | MP0005636_abnormal_mineral_homeostasis | 1.19807787 |
94 | MP0000858_altered_metastatic_potential | 1.19587147 |
95 | MP0001661_extended_life_span | 1.18325443 |
96 | MP0006138_congestive_heart_failure | 1.16477893 |
97 | MP0005508_abnormal_skeleton_morphology | 1.15938135 |
98 | MP0002928_abnormal_bile_duct | 1.14954057 |
99 | MP0004215_abnormal_myocardial_fiber | 1.14594158 |
100 | MP0002295_abnormal_pulmonary_circulatio | 1.14160937 |
101 | MP0003137_abnormal_impulse_conducting | 1.14006690 |
102 | MP0009780_abnormal_chondrocyte_physiolo | 1.12817699 |
103 | MP0002733_abnormal_thermal_nociception | 1.12750249 |
104 | MP0001544_abnormal_cardiovascular_syste | 1.12485767 |
105 | MP0005385_cardiovascular_system_phenoty | 1.12485767 |
106 | MP0000230_abnormal_systemic_arterial | 1.12263913 |
107 | MP0005084_abnormal_gallbladder_morpholo | 1.11527131 |
108 | MP0010329_abnormal_lipoprotein_level | 1.11270705 |
109 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11179006 |
110 | MP0008961_abnormal_basal_metabolism | 1.09991336 |
111 | MP0003385_abnormal_body_wall | 1.09767414 |
112 | MP0002419_abnormal_innate_immunity | 1.08464674 |
113 | MP0003828_pulmonary_edema | 1.06993449 |
114 | MP0003283_abnormal_digestive_organ | 1.06340980 |
115 | MP0002420_abnormal_adaptive_immunity | 1.05888607 |
116 | MP0000013_abnormal_adipose_tissue | 1.05593325 |
117 | MP0001819_abnormal_immune_cell | 1.03917496 |
118 | MP0000689_abnormal_spleen_morphology | 1.01760046 |
119 | MP0010630_abnormal_cardiac_muscle | 1.01565222 |
120 | MP0002429_abnormal_blood_cell | 1.01505293 |
121 | MP0002115_abnormal_skeleton_extremities | 0.98559452 |
122 | MP0003866_abnormal_defecation | 0.98424339 |
123 | MP0001845_abnormal_inflammatory_respons | 0.97608887 |
124 | MP0001790_abnormal_immune_system | 0.97384022 |
125 | MP0005387_immune_system_phenotype | 0.97384022 |
126 | MP0008874_decreased_physiological_sensi | 0.95349527 |
127 | MP0000767_abnormal_smooth_muscle | 0.95234513 |
128 | MP0000685_abnormal_immune_system | 0.95018824 |
129 | MP0010352_gastrointestinal_tract_polyps | 0.94206268 |
130 | MP0005377_hearing/vestibular/ear_phenot | 0.93465339 |
131 | MP0003878_abnormal_ear_physiology | 0.93465339 |
132 | MP0000015_abnormal_ear_pigmentation | 0.93331399 |
133 | MP0000163_abnormal_cartilage_morphology | 0.92627634 |
134 | MP0009765_abnormal_xenobiotic_induced | 0.92592333 |
135 | MP0005023_abnormal_wound_healing | 0.92484297 |
136 | MP0000534_abnormal_ureter_morphology | 0.92430621 |
137 | MP0005025_abnormal_response_to | 0.91769868 |
138 | MP0005666_abnormal_adipose_tissue | 0.91374212 |
139 | MP0009642_abnormal_blood_homeostasis | 0.91133948 |
140 | MP0000716_abnormal_immune_system | 0.90363319 |
141 | MP0003656_abnormal_erythrocyte_physiolo | 0.90343837 |
142 | MP0002722_abnormal_immune_system | 0.89322832 |
143 | MP0004883_abnormal_blood_vessel | 0.89142266 |
144 | MP0000538_abnormal_urinary_bladder | 0.88925059 |
145 | MP0005670_abnormal_white_adipose | 0.87924213 |
146 | MP0002998_abnormal_bone_remodeling | 0.87347830 |
147 | MP0006276_abnormal_autonomic_nervous | 0.84250743 |
148 | MP0001299_abnormal_eye_distance/ | 0.84213370 |
149 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83090409 |
150 | MP0005381_digestive/alimentary_phenotyp | 0.82116868 |
151 | MP0005375_adipose_tissue_phenotype | 0.81302304 |
152 | MP0003950_abnormal_plasma_membrane | 0.80795449 |
153 | MP0005257_abnormal_intraocular_pressure | 0.80078344 |
154 | MP0002135_abnormal_kidney_morphology | 0.79921375 |
155 | MP0001664_abnormal_digestion | 0.79762060 |
156 | MP0009333_abnormal_splenocyte_physiolog | 0.79674919 |
157 | MP0006054_spinal_hemorrhage | 0.76795022 |
158 | MP0003075_altered_response_to | 0.75832668 |
159 | MP0002128_abnormal_blood_circulation | 0.74039806 |
160 | MP0001970_abnormal_pain_threshold | 0.73862460 |
161 | MP0000003_abnormal_adipose_tissue | 0.73005996 |
162 | MP0005174_abnormal_tail_pigmentation | 0.72128358 |
163 | MP0005165_increased_susceptibility_to | 0.71854625 |
164 | MP0005319_abnormal_enzyme/_coenzyme | 0.71495332 |
165 | MP0003718_maternal_effect | 0.70730018 |
166 | MP0003183_abnormal_peptide_metabolism | 0.69739077 |
167 | MP0009785_altered_susceptibility_to | 0.69229629 |
168 | MP0009697_abnormal_copulation | 0.68838056 |
169 | MP0001879_abnormal_lymphatic_vessel | 0.68641353 |
170 | MP0005367_renal/urinary_system_phenotyp | 0.68534977 |
171 | MP0000516_abnormal_urinary_system | 0.68534977 |
172 | MP0004142_abnormal_muscle_tone | 0.62929017 |
173 | MP0002118_abnormal_lipid_homeostasis | 0.60647215 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormal platelet volume (HP:0011876) | 9.83030547 |
2 | Petechiae (HP:0000967) | 9.60582235 |
3 | Purpura (HP:0000979) | 8.75116754 |
4 | Epistaxis (HP:0000421) | 7.75908667 |
5 | Gingival bleeding (HP:0000225) | 6.77734401 |
6 | Hyperlipoproteinemia (HP:0010980) | 5.72143279 |
7 | Abnormal platelet function (HP:0011869) | 5.58435387 |
8 | Impaired platelet aggregation (HP:0003540) | 5.58435387 |
9 | Gout (HP:0001997) | 5.02867629 |
10 | Spontaneous hematomas (HP:0007420) | 4.93564837 |
11 | Muscle fiber splitting (HP:0003555) | 4.82702652 |
12 | Increased circulating renin level (HP:0000848) | 4.55750701 |
13 | Metabolic alkalosis (HP:0200114) | 4.49282632 |
14 | Hypokalemic alkalosis (HP:0001949) | 4.44183230 |
15 | Abnormality of chloride homeostasis (HP:0011422) | 4.41511707 |
16 | Aplasia of the musculature (HP:0100854) | 4.39421108 |
17 | Dyschromatopsia (HP:0007641) | 4.32649935 |
18 | Hypomagnesemia (HP:0002917) | 4.31855842 |
19 | Polyuria (HP:0000103) | 4.18482974 |
20 | Increased purine levels (HP:0004368) | 4.12197544 |
21 | Hyperuricemia (HP:0002149) | 4.12197544 |
22 | Hyperactive renin-angiotensin system (HP:0000841) | 4.05328574 |
23 | Abnormal urine output (HP:0012590) | 3.99207818 |
24 | Abnormality of renal excretion (HP:0011036) | 3.92848709 |
25 | Poikilocytosis (HP:0004447) | 3.90471243 |
26 | Conjunctival telangiectasia (HP:0000524) | 3.89896006 |
27 | Acanthocytosis (HP:0001927) | 3.89321832 |
28 | Muscle fiber inclusion bodies (HP:0100299) | 3.84091814 |
29 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.77371059 |
30 | Abnormal pupillary function (HP:0007686) | 3.75545009 |
31 | Proximal tubulopathy (HP:0000114) | 3.56687968 |
32 | Bruising susceptibility (HP:0000978) | 3.50553759 |
33 | Abnormality of magnesium homeostasis (HP:0004921) | 3.49711827 |
34 | Abnormal drinking behavior (HP:0030082) | 3.46963223 |
35 | Polydipsia (HP:0001959) | 3.46963223 |
36 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.41831560 |
37 | Abnormality of the common coagulation pathway (HP:0010990) | 3.39545480 |
38 | Type 1 muscle fiber predominance (HP:0003803) | 3.36365678 |
39 | Abnormality of purine metabolism (HP:0004352) | 3.31218134 |
40 | Nemaline bodies (HP:0003798) | 3.29525532 |
41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.26177673 |
42 | Tetany (HP:0001281) | 3.21699360 |
43 | Increased density of long bones (HP:0006392) | 3.18007783 |
44 | Ulnar deviation of the wrist (HP:0003049) | 3.17241148 |
45 | Hyporeflexia of lower limbs (HP:0002600) | 3.13843736 |
46 | Round ear (HP:0100830) | 3.11360345 |
47 | Exercise-induced muscle cramps (HP:0003710) | 3.11049675 |
48 | Paralysis (HP:0003470) | 3.08955376 |
49 | Abnormality of lateral ventricle (HP:0030047) | 2.95709042 |
50 | Cardiovascular calcification (HP:0011915) | 2.95026775 |
51 | Hypokalemia (HP:0002900) | 2.94770605 |
52 | Right ventricular cardiomyopathy (HP:0011663) | 2.93242271 |
53 | Distal arthrogryposis (HP:0005684) | 2.90635398 |
54 | Vascular calcification (HP:0004934) | 2.86275352 |
55 | Exercise-induced myalgia (HP:0003738) | 2.84227708 |
56 | Abnormality of the calf musculature (HP:0001430) | 2.84189904 |
57 | Aortic aneurysm (HP:0004942) | 2.80670145 |
58 | Hyperaldosteronism (HP:0000859) | 2.80442553 |
59 | Abnormality of renin-angiotensin system (HP:0000847) | 2.75354264 |
60 | Protrusio acetabuli (HP:0003179) | 2.74684851 |
61 | Hyperglycinuria (HP:0003108) | 2.73067966 |
62 | Hip contracture (HP:0003273) | 2.72598509 |
63 | Abnormality of potassium homeostasis (HP:0011042) | 2.72452731 |
64 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.72192037 |
65 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.70038255 |
66 | Calf muscle hypertrophy (HP:0008981) | 2.67942034 |
67 | Chondrocalcinosis (HP:0000934) | 2.67243383 |
68 | Abnormal auditory evoked potentials (HP:0006958) | 2.65118489 |
69 | Premature rupture of membranes (HP:0001788) | 2.64894242 |
70 | Ketoacidosis (HP:0001993) | 2.63922004 |
71 | Hypercalciuria (HP:0002150) | 2.63441851 |
72 | Abnormality of macrophages (HP:0004311) | 2.61379203 |
73 | Difficulty running (HP:0009046) | 2.60799659 |
74 | Hepatosplenomegaly (HP:0001433) | 2.55928413 |
75 | Stomatitis (HP:0010280) | 2.55924926 |
76 | Renal salt wasting (HP:0000127) | 2.54124622 |
77 | Renal tubular acidosis (HP:0001947) | 2.52537034 |
78 | Increased connective tissue (HP:0009025) | 2.50636777 |
79 | Decreased central vision (HP:0007663) | 2.48628537 |
80 | Metaphyseal cupping (HP:0003021) | 2.48336221 |
81 | Hydroxyprolinuria (HP:0003080) | 2.48008688 |
82 | Abnormality of proline metabolism (HP:0010907) | 2.48008688 |
83 | Alkalosis (HP:0001948) | 2.47997677 |
84 | Abnormality of Sharpey fibers (HP:0100685) | 2.47374410 |
85 | Generalized muscle weakness (HP:0003324) | 2.45179898 |
86 | EMG: myopathic abnormalities (HP:0003458) | 2.44453817 |
87 | Joint hemorrhage (HP:0005261) | 2.42070508 |
88 | Increased IgM level (HP:0003496) | 2.41183334 |
89 | Xanthomatosis (HP:0000991) | 2.40730602 |
90 | Joint swelling (HP:0001386) | 2.38246564 |
91 | Sudden death (HP:0001699) | 2.37829473 |
92 | Hypoplastic left heart (HP:0004383) | 2.36028930 |
93 | Upper limb muscle weakness (HP:0003484) | 2.35998081 |
94 | Anomalous pulmonary venous return (HP:0010772) | 2.30292922 |
95 | Myopathic facies (HP:0002058) | 2.24933255 |
96 | Partial duplication of thumb phalanx (HP:0009944) | 2.23335772 |
97 | Abnormality of iron homeostasis (HP:0011031) | 2.22309208 |
98 | Scapular winging (HP:0003691) | 2.20391781 |
99 | Vascular tortuosity (HP:0004948) | 2.20158699 |
100 | Nausea (HP:0002018) | 2.19129212 |
101 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.17929040 |
102 | Limited hip movement (HP:0008800) | 2.15621703 |
103 | Hypoplastic heart (HP:0001961) | 2.14945285 |
104 | Generalized aminoaciduria (HP:0002909) | 2.14552632 |
105 | Abnormality of glycine metabolism (HP:0010895) | 2.14409963 |
106 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.14409963 |
107 | Hyperkalemia (HP:0002153) | 2.13892869 |
108 | Tinnitus (HP:0000360) | 2.13007981 |
109 | Cervical subluxation (HP:0003308) | 2.11808817 |
110 | Ketosis (HP:0001946) | 2.08705431 |
111 | Knee flexion contracture (HP:0006380) | 2.07381288 |
112 | Partial duplication of the phalanx of hand (HP:0009999) | 2.07342786 |
113 | Arterial thrombosis (HP:0004420) | 2.07199386 |
114 | Encephalitis (HP:0002383) | 2.07180206 |
115 | Facial shape deformation (HP:0011334) | 2.06481005 |
116 | Potter facies (HP:0002009) | 2.06481005 |
117 | Difficulty climbing stairs (HP:0003551) | 2.06138404 |
118 | Abnormality of the pulmonary veins (HP:0011718) | 2.05419230 |
119 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.05235307 |
120 | 3-Methylglutaconic aciduria (HP:0003535) | 2.05190144 |
121 | Thyroid-stimulating hormone excess (HP:0002925) | 2.04847788 |
122 | Increased variability in muscle fiber diameter (HP:0003557) | 2.03729253 |
123 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.03718736 |
124 | Aortic dissection (HP:0002647) | 2.02976658 |
125 | Cerebral aneurysm (HP:0004944) | 2.02480086 |
126 | Myoglobinuria (HP:0002913) | 2.02057970 |
127 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.01741990 |
128 | Thin bony cortex (HP:0002753) | 2.01361602 |
129 | Myocardial infarction (HP:0001658) | 2.01349377 |
130 | Complete atrioventricular canal defect (HP:0001674) | 2.00867219 |
131 | Prolonged bleeding time (HP:0003010) | 11.4514300 |
132 | Menorrhagia (HP:0000132) | 10.5169498 |
133 | Increased mean platelet volume (HP:0011877) | 10.4161270 |
134 | Ventricular fibrillation (HP:0001663) | 1.97068094 |
135 | Papillary thyroid carcinoma (HP:0002895) | 1.95682751 |
136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95668326 |
137 | Spinal rigidity (HP:0003306) | 1.95396127 |
138 | Muscular dystrophy (HP:0003560) | 1.94819440 |
139 | Abnormality of nucleobase metabolism (HP:0010932) | 1.94769777 |
140 | Absent phalangeal crease (HP:0006109) | 1.93174379 |
141 | Episodic fever (HP:0001954) | 1.93137662 |
142 | Chronic obstructive pulmonary disease (HP:0006510) | 1.93113306 |
143 | Obstructive lung disease (HP:0006536) | 1.93113306 |
144 | Abnormal urine phosphate concentration (HP:0012599) | 1.92853555 |
145 | Calcaneovalgus deformity (HP:0001848) | 1.90195525 |
146 | Spontaneous abortion (HP:0005268) | 1.89016517 |
147 | Abnormality of alanine metabolism (HP:0010916) | 1.87498045 |
148 | Hyperalaninemia (HP:0003348) | 1.87498045 |
149 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.87498045 |
150 | Broad metatarsal (HP:0001783) | 1.86687162 |
151 | Nephrolithiasis (HP:0000787) | 1.85379907 |
152 | Abnormality of urine glucose concentration (HP:0011016) | 1.85053601 |
153 | Glycosuria (HP:0003076) | 1.85053601 |
154 | Hyperthyroidism (HP:0000836) | 1.83221106 |
155 | Male infertility (HP:0003251) | 1.80494031 |
156 | Basal ganglia calcification (HP:0002135) | 1.78045558 |
157 | Increased serum ferritin (HP:0003281) | 1.75940338 |
158 | Eczematoid dermatitis (HP:0000976) | 1.71694821 |
159 | Biliary tract neoplasm (HP:0100574) | 1.69863044 |
160 | Tongue fasciculations (HP:0001308) | 1.69187460 |
161 | Hypophosphatemic rickets (HP:0004912) | 1.69146757 |
162 | Type 2 muscle fiber atrophy (HP:0003554) | 1.67251860 |
163 | Abnormality of the prostate (HP:0008775) | 1.67031160 |
164 | Muscle fibrillation (HP:0010546) | 1.66796066 |
165 | Vertigo (HP:0002321) | 1.66532908 |
166 | Muscle fiber atrophy (HP:0100295) | 1.66401709 |
167 | Autoimmune hemolytic anemia (HP:0001890) | 1.65575791 |
168 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.63545965 |
169 | Dysautonomia (HP:0002459) | 1.61607087 |
170 | Polycythemia (HP:0001901) | 1.60936236 |
171 | Arthropathy (HP:0003040) | 1.60102936 |
172 | Chest pain (HP:0100749) | 1.58907591 |
173 | Uterine leiomyosarcoma (HP:0002891) | 1.58486577 |
174 | Leiomyosarcoma (HP:0100243) | 1.58486577 |
175 | Mucosal telangiectasiae (HP:0100579) | 1.58292686 |
176 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.58185443 |
177 | Congenital sensorineural hearing impairment (HP:0008527) | 1.55100902 |
178 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.54121017 |
179 | Abnormal ciliary motility (HP:0012262) | 1.53036168 |
180 | Distal lower limb amyotrophy (HP:0008944) | 1.52888606 |
181 | Mitral stenosis (HP:0001718) | 1.52704974 |
182 | Recurrent abscess formation (HP:0002722) | 1.51140346 |
183 | Thrombophlebitis (HP:0004418) | 1.47001687 |
184 | Bladder neoplasm (HP:0009725) | 1.44461452 |
185 | Bladder carcinoma (HP:0002862) | 1.44461452 |
186 | Polyphagia (HP:0002591) | 1.42966075 |
187 | Recurrent bacterial skin infections (HP:0005406) | 1.41816932 |
188 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.40289717 |
189 | Weak cry (HP:0001612) | 1.39826818 |
190 | Leukocytosis (HP:0001974) | 1.39773636 |
191 | Testicular neoplasm (HP:0010788) | 1.37814980 |
192 | Diplopia (HP:0000651) | 1.36815330 |
193 | Abnormality of binocular vision (HP:0011514) | 1.36815330 |
194 | Pulmonary embolism (HP:0002204) | 1.36631286 |
195 | Cerebral ischemia (HP:0002637) | 1.35360898 |
196 | Infertility (HP:0000789) | 1.35237881 |
197 | Dysostosis multiplex (HP:0000943) | 1.34581781 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK4 | 6.47309361 |
2 | RIPK4 | 5.10714747 |
3 | WNK3 | 4.47558737 |
4 | TTN | 3.62724776 |
5 | OXSR1 | 3.61193420 |
6 | OBSCN | 3.49164110 |
7 | TEC | 3.19364388 |
8 | EIF2AK1 | 3.06703792 |
9 | BTK | 2.87929308 |
10 | STK38L | 2.61450398 |
11 | LATS1 | 2.53249265 |
12 | TAOK3 | 2.26157778 |
13 | CSF1R | 2.24999699 |
14 | SYK | 2.23870916 |
15 | ZAK | 2.16854468 |
16 | WNK1 | 2.16371426 |
17 | DMPK | 2.12743886 |
18 | GRK5 | 2.09332081 |
19 | PDK4 | 2.02909841 |
20 | PDK3 | 2.02909841 |
21 | TRIB3 | 2.00726379 |
22 | STK39 | 1.95513953 |
23 | FGR | 1.93582147 |
24 | BMPR2 | 1.90710212 |
25 | ZAP70 | 1.90114692 |
26 | PIK3CA | 1.82504888 |
27 | PIK3CG | 1.82158222 |
28 | GRK6 | 1.80653799 |
29 | RIPK1 | 1.68792634 |
30 | EPHA3 | 1.59103435 |
31 | PAK3 | 1.57024865 |
32 | ADRBK2 | 1.54816919 |
33 | NEK1 | 1.53675718 |
34 | PDK2 | 1.51086399 |
35 | ACVR1B | 1.42796163 |
36 | HCK | 1.41316593 |
37 | BLK | 1.40739168 |
38 | EPHB2 | 1.40697318 |
39 | BCKDK | 1.38064736 |
40 | MYLK | 1.37261899 |
41 | MAPKAPK3 | 1.35984842 |
42 | PHKG2 | 1.33777953 |
43 | PHKG1 | 1.33777953 |
44 | PDGFRA | 1.32508130 |
45 | PLK2 | 1.31877450 |
46 | LRRK2 | 1.30025130 |
47 | FES | 1.28980454 |
48 | STK38 | 1.24564640 |
49 | MAP3K7 | 1.23198815 |
50 | PTK2B | 1.22200279 |
51 | DDR2 | 1.20449990 |
52 | PAK1 | 1.18835429 |
53 | PTK2 | 1.18259823 |
54 | LYN | 1.17964465 |
55 | TNK2 | 1.15550999 |
56 | FRK | 1.13020933 |
57 | IKBKB | 1.11987297 |
58 | PAK2 | 1.11518541 |
59 | LATS2 | 1.09606466 |
60 | TXK | 1.08792644 |
61 | ERN1 | 1.08434944 |
62 | TGFBR2 | 1.07004117 |
63 | ADRBK1 | 0.96759546 |
64 | PIM2 | 0.95628256 |
65 | FER | 0.94874601 |
66 | ROCK1 | 0.94188908 |
67 | IRAK1 | 0.93959536 |
68 | MAP3K5 | 0.91494913 |
69 | CSK | 0.90560621 |
70 | ITK | 0.88779204 |
71 | SGK494 | 0.88534487 |
72 | SGK223 | 0.88534487 |
73 | TNIK | 0.86729429 |
74 | DYRK1B | 0.85494718 |
75 | STK10 | 0.84928264 |
76 | EPHB1 | 0.83393632 |
77 | ARAF | 0.81905303 |
78 | MATK | 0.81273575 |
79 | PTK6 | 0.80862215 |
80 | MET | 0.80279511 |
81 | MARK3 | 0.78766756 |
82 | NEK9 | 0.76665862 |
83 | MST1R | 0.76079609 |
84 | STK3 | 0.74715106 |
85 | SGK3 | 0.74406939 |
86 | MUSK | 0.71791225 |
87 | MAP2K3 | 0.71069911 |
88 | PAK4 | 0.70560381 |
89 | BMPR1B | 0.69139366 |
90 | PDK1 | 0.67652128 |
91 | SIK3 | 0.67614897 |
92 | TRIM28 | 0.67131615 |
93 | PRKAA1 | 0.66719940 |
94 | ILK | 0.65791385 |
95 | PNCK | 0.63935190 |
96 | DAPK2 | 0.63537764 |
97 | JAK3 | 0.63243517 |
98 | ERBB2 | 0.63111675 |
99 | PKN1 | 0.62894338 |
100 | NUAK1 | 0.62455089 |
101 | MTOR | 0.61905127 |
102 | GSK3A | 0.61748512 |
103 | MAPK12 | 0.58180189 |
104 | TAOK2 | 0.56948968 |
105 | MAP2K1 | 0.55071847 |
106 | STK4 | 0.55034608 |
107 | LCK | 0.53786011 |
108 | FGFR4 | 0.52451722 |
109 | PINK1 | 0.51836894 |
110 | BMX | 0.51729465 |
111 | SGK2 | 0.51422307 |
112 | PRKAA2 | 0.51355108 |
113 | STK24 | 0.51250128 |
114 | PKN2 | 0.50305525 |
115 | TRPM7 | 0.49903258 |
116 | SGK1 | 0.48897067 |
117 | MAP3K12 | 0.48703411 |
118 | PRKACG | 0.48547436 |
119 | MAP3K3 | 0.48314254 |
120 | PRKD1 | 0.47866504 |
121 | MINK1 | 0.47340542 |
122 | MAP4K1 | 0.46488222 |
123 | FYN | 0.46411420 |
124 | NME1 | 0.46176173 |
125 | CDC42BPA | 0.45325254 |
126 | CAMK1G | 0.44938459 |
127 | ABL2 | 0.44376869 |
128 | CAMKK2 | 0.43154913 |
129 | TIE1 | 0.42953516 |
130 | PDGFRB | 0.42689540 |
131 | ROCK2 | 0.42357577 |
132 | TLK1 | 0.42280187 |
133 | JAK1 | 0.42187077 |
134 | PRKG1 | 0.41491050 |
135 | GRK1 | 0.41145488 |
136 | CDK6 | 0.40181679 |
137 | JAK2 | 0.39628719 |
138 | PRKD2 | 0.39501199 |
139 | MST4 | 0.39081700 |
140 | BCR | 0.38388442 |
141 | MOS | 0.37870250 |
142 | PDPK1 | 0.37410118 |
143 | LMTK2 | 0.36941188 |
144 | TESK2 | 0.35966262 |
145 | TAOK1 | 0.35806427 |
146 | PRKCH | 0.34982639 |
147 | PRKD3 | 0.34819863 |
148 | MAPK13 | 0.34812473 |
149 | RET | 0.34548236 |
150 | IRAK4 | 0.34321747 |
151 | PRKCQ | 0.33839934 |
152 | INSR | 0.33820836 |
153 | PRKCD | 0.33739863 |
154 | YES1 | 0.33649702 |
155 | NLK | 0.32770966 |
156 | SIK1 | 0.32593185 |
157 | LIMK1 | 0.31613881 |
158 | DAPK1 | 0.31164447 |
159 | NTRK1 | 0.30488695 |
160 | PRKCE | 0.30027852 |
161 | IRAK2 | 0.29684609 |
162 | PIM1 | 0.29381029 |
163 | FGFR3 | 0.29322417 |
164 | DAPK3 | 0.29095935 |
165 | MAP2K4 | 0.28759026 |
166 | IRAK3 | 0.27998601 |
167 | PRKCB | 0.27772907 |
168 | PRKCA | 0.27571116 |
169 | PRKG2 | 0.27485390 |
170 | FGFR1 | 0.27467988 |
171 | ERBB4 | 0.27148282 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.73372943 |
2 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 3.12423164 |
3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.80317262 |
4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.76117415 |
5 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.64907932 |
6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.64676792 |
7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.56378474 |
8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.51188243 |
9 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.46591755 |
10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.43406954 |
11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.42924937 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42423701 |
13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.40962477 |
14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.33085510 |
15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.16767347 |
16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.15884355 |
17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.12290564 |
18 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.01988783 |
19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.93157401 |
20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.92787757 |
21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.90039055 |
22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.88080253 |
23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.85143452 |
24 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.79563678 |
25 | Gap junction_Homo sapiens_hsa04540 | 1.79057564 |
26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67381494 |
27 | Focal adhesion_Homo sapiens_hsa04510 | 1.65656109 |
28 | Peroxisome_Homo sapiens_hsa04146 | 1.61833265 |
29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.59208820 |
30 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.46537262 |
31 | Lysine degradation_Homo sapiens_hsa00310 | 1.43628567 |
32 | Bile secretion_Homo sapiens_hsa04976 | 1.41777783 |
33 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.40913761 |
34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40501679 |
35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36200028 |
36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.35375603 |
37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.35178310 |
38 | Alcoholism_Homo sapiens_hsa05034 | 1.32733227 |
39 | Endocytosis_Homo sapiens_hsa04144 | 1.29028383 |
40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28629249 |
41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.28017952 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21094500 |
43 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.19643277 |
44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17924867 |
45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17139403 |
46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16650968 |
47 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.14840595 |
48 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.14124015 |
49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13412019 |
50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12664224 |
51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11820102 |
52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.11025752 |
53 | Amoebiasis_Homo sapiens_hsa05146 | 1.10276245 |
54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.08683210 |
55 | Phagosome_Homo sapiens_hsa04145 | 1.08407054 |
56 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08047099 |
57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07790237 |
58 | Tight junction_Homo sapiens_hsa04530 | 1.07378546 |
59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.05528849 |
60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04581039 |
61 | Adherens junction_Homo sapiens_hsa04520 | 1.04402740 |
62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.03841701 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02658501 |
64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02530500 |
65 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.02018643 |
66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01264595 |
67 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99689909 |
68 | Olfactory transduction_Homo sapiens_hsa04740 | 0.98920885 |
69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.96745948 |
70 | Morphine addiction_Homo sapiens_hsa05032 | 0.96379023 |
71 | Long-term depression_Homo sapiens_hsa04730 | 0.95290126 |
72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.94782832 |
73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93404191 |
74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92275691 |
75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90858421 |
76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.88758012 |
77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88013802 |
78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.86901727 |
79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86140043 |
80 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85161603 |
81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83457544 |
82 | Bladder cancer_Homo sapiens_hsa05219 | 0.83216269 |
83 | Insulin resistance_Homo sapiens_hsa04931 | 0.82729875 |
84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80849877 |
85 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79680593 |
86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.77729360 |
87 | Mineral absorption_Homo sapiens_hsa04978 | 0.75590093 |
88 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.75505229 |
89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74705821 |
90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74237620 |
91 | Asthma_Homo sapiens_hsa05310 | 0.74036568 |
92 | Allograft rejection_Homo sapiens_hsa05330 | 0.71874268 |
93 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71853498 |
94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71560991 |
95 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70923278 |
96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70650512 |
97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70551847 |
98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69778909 |
99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68452297 |
100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67531648 |
101 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66616389 |
102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65258149 |
103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64684242 |
104 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64038354 |
105 | GABAergic synapse_Homo sapiens_hsa04727 | 0.63381294 |
106 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62240049 |
107 | Lysosome_Homo sapiens_hsa04142 | 0.61950798 |
108 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.61949826 |
109 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61757405 |
110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60926853 |
111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59528701 |
112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59454453 |
113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58193494 |
114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57213245 |
115 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.56191831 |
116 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55403934 |
117 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54822655 |
118 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54618997 |
119 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54237296 |
120 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53374735 |
121 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52309663 |
122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51253335 |
123 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.51130837 |
124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51118923 |
125 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.51028679 |
126 | Melanoma_Homo sapiens_hsa05218 | 0.49894574 |
127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49656633 |
128 | Legionellosis_Homo sapiens_hsa05134 | 0.49602577 |
129 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48974843 |
130 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48917428 |
131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48769137 |
132 | Phototransduction_Homo sapiens_hsa04744 | 0.48561815 |
133 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47559172 |
134 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47055017 |
135 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46995302 |
136 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46599545 |
137 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46479504 |
138 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46092569 |
139 | Tuberculosis_Homo sapiens_hsa05152 | 0.45962142 |
140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45928027 |
141 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45665340 |
142 | Renin secretion_Homo sapiens_hsa04924 | 0.44324322 |
143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44011672 |
144 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43669605 |
145 | Mismatch repair_Homo sapiens_hsa03430 | 0.40967287 |
146 | Salmonella infection_Homo sapiens_hsa05132 | 0.40931548 |
147 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.40777292 |
148 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40379991 |
149 | Apoptosis_Homo sapiens_hsa04210 | 0.40139402 |
150 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40075461 |
151 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.40068230 |
152 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39693661 |
153 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39273412 |
154 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39235100 |
155 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38957955 |
156 | Glioma_Homo sapiens_hsa05214 | 0.38510571 |
157 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.37911610 |
158 | Platelet activation_Homo sapiens_hsa04611 | 0.37256539 |
159 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35657468 |
160 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34994569 |
161 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34329459 |
162 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33533824 |
163 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31710291 |
164 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30788462 |
165 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30503954 |
166 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30469159 |
167 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30031929 |
168 | Shigellosis_Homo sapiens_hsa05131 | 0.29576425 |
169 | Malaria_Homo sapiens_hsa05144 | 0.28964997 |
170 | Prostate cancer_Homo sapiens_hsa05215 | 0.26106897 |